243 related articles for article (PubMed ID: 17650424)
21. Inactivation of COX-2, HMLH1 and CDKN2A gene by promoter methylation in gastric cancer: relationship with histological subtype, tumor location and Helicobacter pylori genotype.
Alves MK; Ferrasi AC; Lima VP; Ferreira MV; de Moura Campos Pardini MI; Rabenhorst SH
Pathobiology; 2011; 78(5):266-76. PubMed ID: 21849808
[TBL] [Abstract][Full Text] [Related]
22. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
23. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
24. Hypermethylation of the hMLH1 gene promoter in solitary and multiple gastric cancers with microsatellite instability.
Sakata K; Tamura G; Endoh Y; Ohmura K; Ogata S; Motoyama T
Br J Cancer; 2002 Feb; 86(4):564-7. PubMed ID: 11870538
[TBL] [Abstract][Full Text] [Related]
25. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
26. Aberrant DNA methylation in non-neoplastic gastric mucosa of H. Pylori infected patients and effect of eradication.
Perri F; Cotugno R; Piepoli A; Merla A; Quitadamo M; Gentile A; Pilotto A; Annese V; Andriulli A
Am J Gastroenterol; 2007 Jul; 102(7):1361-71. PubMed ID: 17509026
[TBL] [Abstract][Full Text] [Related]
27. An inverse correlation between Interleukin-6 and select gene promoter methylation in patients with gastric cancer.
Tang LP; Cho CH; Hui WM; Huang C; Chu KM; Xia HH; Lam SK; Rashid A; Wong BC; Chan AO
Digestion; 2006; 74(2):85-90. PubMed ID: 17139167
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation status of E-cadherin, hMLH1, and p16 genes in nonneoplastic gastric epithelia.
Waki T; Tamura G; Tsuchiya T; Sato K; Nishizuka S; Motoyama T
Am J Pathol; 2002 Aug; 161(2):399-403. PubMed ID: 12163364
[TBL] [Abstract][Full Text] [Related]
29. Promoter methylation profile in gallbladder cancer.
Roa JC; Anabalón L; Roa I; Melo A; Araya JC; Tapia O; de Aretxabala X; Muñoz S; Schneider B
J Gastroenterol; 2006 Mar; 41(3):269-75. PubMed ID: 16699861
[TBL] [Abstract][Full Text] [Related]
30. Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma.
Hibi K; Sakata M; Yokomizo K; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
Anticancer Res; 2009 Dec; 29(12):5053-5. PubMed ID: 20044616
[TBL] [Abstract][Full Text] [Related]
31. EBV-infection in cardiac and non-cardiac gastric adenocarcinomas is associated with promoter methylation of p16, p14 and APC, but not hMLH1.
Geddert H; Zur Hausen A; Gabbert HE; Sarbia M
Anal Cell Pathol (Amst); 2010; 33(3):143-9. PubMed ID: 20978327
[TBL] [Abstract][Full Text] [Related]
32. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
33. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
34. Role of hMLH1 and E-cadherin promoter methylation in gastric cancer progression.
Moghbeli M; Moaven O; Memar B; Raziei HR; Aarabi A; Dadkhah E; Forghanifard MM; Manzari F; Abbaszadegan MR
J Gastrointest Cancer; 2014 Mar; 45(1):40-7. PubMed ID: 24022108
[TBL] [Abstract][Full Text] [Related]
35. Concurrent hypermethylation of multiple tumor-related genes in gastric carcinoma and adjacent normal tissues.
Leung WK; Yu J; Ng EK; To KF; Ma PK; Lee TL; Go MY; Chung SC; Sung JJ
Cancer; 2001 Jun; 91(12):2294-301. PubMed ID: 11413518
[TBL] [Abstract][Full Text] [Related]
36. Implication of Reprimo and hMLH1 gene methylation in early diagnosis of gastric carcinoma.
Liu L; Yang X
Int J Clin Exp Pathol; 2015; 8(11):14977-82. PubMed ID: 26823831
[TBL] [Abstract][Full Text] [Related]
37. [Promoter methylation profile in breast cancer].
Roa JC; Anabalón L; Tapia O; Martínez J; Araya JC; Villaseca M; Guzmán P; Roa I
Rev Med Chil; 2004 Sep; 132(9):1069-77. PubMed ID: 15543763
[TBL] [Abstract][Full Text] [Related]
38. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
39. [Studies of promoter methylation status and protein expression of E-cadherin gene in associated progression stages of gastric cancer].
Zheng ZH; Sun XJ; Ma MC; Hao DM; Liu YH; Sun KL
Yi Chuan Xue Bao; 2003 Feb; 30(2):103-8. PubMed ID: 12776596
[TBL] [Abstract][Full Text] [Related]
40. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
Konishi K; Shen L; Wang S; Meltzer SJ; Harpaz N; Issa JP
Gastroenterology; 2007 Apr; 132(4):1254-60. PubMed ID: 17408633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]